Serhii Derkach

Serhii Derkach

Auto-generated profile, based on publicly available information

Serhii Derkach

National University of Life and Environmental Sciences of Ukraine

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2019 in Scientific Messenger of LNU of Veterinary Medicine and Biotechnologies. Series: Veterinary Sciences
Verified
Journal Article
Open access
PDF file
VDV. B. Dukhnitsky
V. B. Dukhnitsky
IDI. M. Derkach
I. M. Derkach
SDS. S. Derkach
S. S. Derkach
IFIgor Fritsky
Igor Fritsky
MPM. O. Plutenko
M. O. Plutenko
The article presents the results of studies of chronic toxicity of the Iron in the rare unconventional valence – IV. During long-term use of the Iron(IV) clathrochelate complexes for white rats we have established the dynamics of the body weight of rats, the relative coefficients of mass of the internal organs, the content of hemoglobin and morphological parameters of blood, biochemical parameters of blood serum of animals of this species. The daily drinking of solution of the Iron(IV) clathrochelate complexes at the doses of 500 and 1000 mg/kg b. w. resulted in a decrease in body weight, an increase in the relative indices of masses of liver and kidney, and a decrease in the relative indices of masses of  spleen and heart on 30th day. The hemoglobin content in the blood of rats of the experimental group was less than the control indicator by 3–47% (P < 0.05), which is evidence of inhibition of its synthesis under the influence of the Iron (IV) clathrochelatе. Changes in the morphological composition of the blood were characterized by marked leukocytopenia. The use of rats of a solution of the Iron (IV) clathrochelate complexes at doses of 500 and 1000 mg/kg b. w. caused the development of hypoproteinemia, hypercreatinemia and hyperurinemia. Iron(IV) clathrochelate complexes reduced alaninaminotransferase activity in the serum of rats of both experimental groups by 15–80% (P < 0.05); aspartataminotransferase activity increased significantly by day 10 and decreased by day 30; the activity of alkaline phosphatase was independent of the doses of the drug during the experimental period. The content of Calcium total, Phosphor inorganic and Iron in the serum of rats of the experimental groups was at the level of indicators in the animals of the control group. Consequently, comprehensive studies of the effects of solution of the Iron (IV) clathrochelate complexes at doses of 500 and 1000 mg/kg b. w. were performed for the first time with long-term administration to white rats, which revealed the main patterns of metabolic disorders and physiological functions.

19 October 2022 in Potravinarstvo Slovak Journal of Food Sciences
Verified
Journal Article
Open access
PDF file
YZYurii Zhuk
Yurii Zhuk
RZRuslan Zaritskyi
Ruslan Zaritskyi
DDDenys Dreval
Denys Dreval
SDSerhii Derkach
Serhii Derkach
VKVitalii Kovpak
Vitalii Kovpak
IKIryna Kharsika
Iryna Kharsika
Mastitis is one of the most common diseases on dairy farms. It causes significant economic damage associated with the cost of treating sick cows, reduced milk yield and quality indicators of dairy products, and the risk of premature culling of animals. Treatment of cows with mastitis on dairy farms is carried out mainly with antimicrobial drugs, which are usually used without a preliminary test to identify the causative agent of the disease and determine its sensitivity to antimicrobial substances, which is an important part of the effectiveness of therapy. Increasing the resistance of bacteria to antimicrobial substances poses a threat not only to the animal but also to humans, as a consumer of dairy products. The availability of data on the sensitivity of mastitis pathogens to antimicrobial drugs makes it possible for veterinary doctors to choose the most effective antibiotic for treating animals with the shortest duration of treatment. The presented results of studies of breast secret samples taken from cows indicate that in 57.5% of cases, contagious pathogens of mastitis were identified. In particular, Streptococcus agalactiae made 24.1%, Staphylococcus aureus – 18.4%, Corynebacterium spp. – 7.2%, Streptococcus dysgalactiae– 5.6%, Streptococcus uberis – 2.2%. Environmental pathogens accounted for 42.5% of the total number of isolated isolates, among which Streptococci represented gram-positive microflora at 11.5 Streptococcuscus spp. (6.2% Streptococcuscus parauberis (4.4% Streptococcuscus Bovis (0.9%) and Staphylococcus spp. – 10.3%. Gram-negative microflora is 20.6%, among which the largest percentage belongs to E. coli – 8.4% and Klebsiella pneumonia – 1.9%. Mastitis caused by yeast accounted for 1.4% of all diagnosed pathogens. Antimicrobial sensitivity was evaluated using the disk diffusion method (Kirby-Bauer). According to the results of determining the sensitivity of mastitis pathogens to antimicrobial substances, it was found that the highest sensitivity of the isolated isolates was to Ceftiofur, Amoxicillin/clavulanic acid, Rifampicin, Amoxicillin, Gentamicin, Ampicillin, Bacitracin, Cephalexin, Cloxacillin, Enrofloxacin, Trimethoprim/sulfamethoxazole, Oxytetracycline, Lincomycin. The least sensitive – to Spiramycin, Tylosin, streptomycin, neomycin, Marbofloxacin, Tilmicosin, and Danofloxacin.

27 November 2021 in Scientific Messenger of LNU of Veterinary Medicine and Biotechnologies. Series: Veterinary Sciences
Verified
Journal Article
Open access
PDF file
VDV. B. Dukhnitskyi
V. B. Dukhnitskyi
IDI. M. Derkach
I. M. Derkach
SDS. S. Derkach
S. S. Derkach
The degree of the physiological development of the body of piglets in the first months after birth is important because, during this period, there is an active formation of many organism systems, including those that provide homeostasis. The resistance of piglets to diseases of various etiologies during life depends on the formation of the immune system. Our study aimed to assess the immune status of piglets born to sows that received injections of solutions of Iron(IV) clatrochelate and cyanocobalamin during pregnancy. To achieve this goal, two groups of newborn piglets-analogs were formed during their retention with suckling sows – control and experimental, 15 animals each. Piglets from 5 sows (3 from each) were injected into the experimental group, which were injected 10 ml of 10 % solution of Iron(IV) clatrochelate and cyanocobalamin solution twice during pregnancy (14 and 7 days before the expected farrowing) intramuscularly. Piglets of the control group, according to the traditional scheme of prevention of iron deficiency anemia on the second day of life, were administered irondextran drug uniferon (200 mg of iron (III) per injection). Piglets and sows were observed for two months; for studies of the content of immunoglobulins in the piglets' serum, the blood samples were taken at 1, 5, 12, and 30 days of life. During the experiment, the indicators of the content of immunoglobulins of classes G, A, M in the serum of piglets of the experimental group and the dynamics of their changes within 30 days after birth did not differ from the control. Two injections of 10 % solution of Iron(IV) clatrochelate in a dose of 10 ml in combination with cyanocobalamin injections at a dose of 500 mg of active substance to pregnant sows 14 and 7 days before the expected farrowing did not adversely affect the immune status of newborn piglets. Furthermore, this has a high prophylactic effect against iron deficiency anemia.

24 February 2018 in Scientific Messenger of LNU of Veterinary Medicine and Biotechnologies. Series: Veterinary Sciences
Verified
Journal Article
Open access
PDF file
IDI.M. Derkach
I.M. Derkach
SDS.S. Derkach
S.S. Derkach
ISI.O. Sotnichenko
I.O. Sotnichenko
The article presents the results of researches of the national market of feed additives, prepared feeds and premixes containing Ferum, registered in Ukraine (by the date 1.03.2018). It has been established that, unlike complexes of iron and dextran in the form of injectable solutions, such pharmaceutical products as feed additives, ready-made fodders and premixes containing Ferum are characterized by a variety of release forms for different species of animals and birds. The number of such products is 55, among them 14 items (26%) are products of production of Ukraine, while this pharmaceutical product for poultry is offered mainly by Polish manufacturers. The market of this group of products for small animals is characterized by a large variety of flavoring properties and forms of release: tablets, powders, granules, flakes, jelly or lime slices, etc. There are only three producers of Ukraine of such pharmaceutical products in the Ukrainian market, while the largest number is offered by companies of Germany and Czech Republic. In addition, the company Vita Traat (Germany) offers vitracraft in the form of pellets as a feed for decorative chinchillas. In the pharmaceutical market of complexes of feed additives, prepared feeds and premixes containing Ferum for various types of animals and poultry. There is a trend that manufacturers, in addition to the specifics of the species, age, physiological processes, and for products for dogs and cats their breed too, take into account the modern needs of the ukrainian consumers, for example, Cargill Poland Sp., Department of Kishkovo, Plant of Premixes of the LNB (Poland) exports to Ukraine 5 types of premixes for broilers. The range of feed additives, ready forages and premixes containing Ferum for bovine animals is less varied, but besides the dry dosage forms, there is a feed additive for calves in the form of calf id peas (Inform Nutrishin Island, Ltd., Ireland). In addition, iron is a part of the substitute of milk for calves. In the national market, there are also Ferum-containing feed additives for animals of different species, which are available in the form of solutions for oral use.

7 May 2020 in Scientific Messenger of LNU of Veterinary Medicine and Biotechnologies. Series: Veterinary Sciences
Verified
Journal Article
Open access
PDF file
VDV. B. Dukhnitsky
V. B. Dukhnitsky
IDI. M. Derkach
I. M. Derkach
SDS. S. Derkach
S. S. Derkach
IFIgor Fritsky
Igor Fritsky
MPM. O. Plutenko
M. O. Plutenko
VLV. M. Lozovy
V. M. Lozovy
During the preclinical studies of new drugs, the study of the degree of manifestation of their irritant and allergenic effects affects subsequent clinical studies, for example the routes of administration, the need to add excipients to reduce irritation. The article presents the results of studies of the irritant effects and allergenic properties of the Iron in rare unconventional valence – IV. The irritant effect of the Iron(IV) clathrochelate complexes on the skin was studied comprehensively. 20 rabbits were divided into 4 groups (control and three experimental), 5 animals each. The ointment on the vaseline and aqueous solution of the Iron(IV) clathrochelate complexes was applied to the skin of rabbits of the experimental groups. Also this solution was introduced subcutaneously. The investigated dosage forms were used at a dose of 1 ml/kg body weight (based on the active ingredient 500 mg/kg body weight of the laboratory animal). The results of the studies showed that of the Iron(IV) clathrochelate complexes has no irritant properties when used externally and is characterized by a lack of local reaction by subcutaneous injection. Determination of allergenic properties was performed by detecting itching and swelling in the guinea pigs in animals which were sensitized with this substance. In addition, in order to assess the severity of the inflammatory reaction, the skin temperature was determined before the experiment and on the 20th day of the experiment, and the skin fold thickness was measured using a caliper. The results of the studies showed that there is no allergic action of the Iron(IV) clathrochelate complexes. The results of the ophthalmic test on laboratory animals confirmed the data obtained.Therefore, comprehensive studies of the irritant and allergenic effects of the Iron(IV) clathrochelate complexes were performed for the first time. The Iron(IV) clathrochelate complexes in the form of ointment and solution does not irritate the skin and mucous membranes and has no allergenic properties to the body of the laboratory animals.

28 June 2019 in Вісник Полтавської державної аграрної академії
Verified
Journal Article
Closed access
ВДВ. Б. Духницький
В. Б. Духницький
ІДІ. М. Деркач
І. М. Деркач
СДС. С. Деркач
С. С. Деркач
ІФІ. О. Фрицький
І. О. Фрицький
МПМ. О. Плутенко
М. О. Плутенко
У системі токсикометричних показників надзвичайно важливим є встановлення ступеня небезпе-ки хронічної дії препаратів (кумулятивних властивостей) за умови низької інтенсивності впливу.Особливо необхідними є такі дослідження для сполук важких металів, оскільки, як відомо, вони ма-ють виражену кумулятивну здатність. Метою дослідження було вивчення кумулятивних властиво-стей Феруму з високою валентністю – IV у формі клатрохелату. Для досліджень було сформованодослідну і контрольну групи білих щурів по 6 тварин у кожній. Водний розчин клатрохелату Феру-му(ІV) в об’ємі 5 мл вводили щоденно внутрішньо за допомогою металевого зонда. Тваринам дослід-ної групи введення препарату починали з дози 500 мг/кг маси тіла, що становило 1/10 частину відмаксимальної дози. Через кожні чотири доби дозу клатрохелату Феруму(ІV) збільшували у 1,5 рази.Тваринам контрольної групи вводили ізотонічний розчин натрію хлориду об’ємом 5 мл. У результатіпроведених досліджень було встановлено індекс кумуляції досліджуваного комплексу, який стано-вить 6,88 одиниць, що вказує на його слабо виражену кумулятивну активність. Контроль за дина-мікою змін маси тіла тварин упродовж 24 діб засвідчив, що за умови щоденного введення клат-рохелату Феруму(IV) у наростаючій дозі спочатку їх масa тіла зростає, а з 12 доби знижується по-рівняно з контролем. Не виявлено значних відхилень коефіцієнтів відносної маси печінки, нирок і сер-ця, однак відносний коефіцієнт маси селезінки знизився на 41 % порівняно з контролем, що поясню-ється ймовірно розвитком атрофічних процесів у цьому органі. Клатрохелат Феруму(IV) стимулю-юче впливав на гемоцитопоез, що проявлялося збільшенням кількості еритроцитів, проте на фонізниження рівня гемоглобіну (p<0,001) та показника гематокриту у тварин дослідної групи, відпо-відно на 22,7 % та 10 % порівняно з показниками у тварин контрольної групи. У цьому разі кількістьлейкоцитів зменшувалася майже на 39,0 %, що вказувало на наявність запальних або інших патоло-гічних процесів в організмі щурів дослідної групи. Отримані результати біохімічних досліджень си-роватки крові вказували на пригнічення протеїнсинтезувальної функції в організмі щурів, підтвер-дженням чого є показники щодо активності лужної фосфатази та вміст протеїну загального і аль-бумінів. Встановлено стимуляцію глікогенолізу, оскільки показник глюкози в сироватці крові щурівзростав на 36,6 % порівняно з контролем. Зростання вмісту креатиніну на 8,6 % засвідчує про не-значні порушення функції нирок. Змін показників, що відображають функціональний стан роботибагатьох органів та систем в організмі, таких як активність аспартат- та аланінамінотрансферазі сечовини нами не встановлено. Також вміст Кальцію та Фосфору в сироватці крові щурів не змі-нювався. Вищеокреслене вказує на матеріальну кумуляцію як її різновид, що є характерним для куму-ляції важких металів.